Chemical Compound
alpha(sub 2)-Rhodomycinone RDC
CAS Registry Number
86944-87-8
Primary Record
alpha(sub 2)-Rhodomycinone RDC
- In stock
- 4,527 g
- Purity
- 98.9 %
- CAS
- 86944-87-8
Compound Identifiers & Properties
- CAS
- 86944-87-8
- PubChem CID
- 174598
- SMILES
- CC[C@]1(C[C@@H](C2=CC3=C(C(=C2[C@H]1O[C@H]4C[C@@H]([C@@H]([C@@H](O4)C)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6CCC(=O)[C@@H](O6)C)O)N(C)C)O)C(=O)C7=C(C=CC(=C7C3=O)O)O)O)O
- Canonical SMILES
- CC[C@@]1(O)C[C@H](O)c2cc3c(c(O)c2[C@H]1O[C@H]1C[C@H](N(C)C)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O2)[C@H](C)O1)C(=O)c1c(O)ccc(O)c1C3=O
Names & Synonyms
- alpha(sub 2)-Rhodomycinone RDC
- CG 11
- AC1L5BDM
- RefChem:124750
- CG-11
- SCHEMBL29659744
- DTXSID501007210
- CID174598
- C40-H51-N-O15
- J22.187B
- LS-94101
- 86944-87-8
- (7S,9R,10R)-10-[(2S,4S,5S,6S)-4-(dimethylamino)-5-[(2S,4S,5S,6S)-4-hydroxy-6-methyl-5-[(2R,6S)-6-methyl-5-oxooxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-9-ethyl-1,4,7,9,11-pentahydroxy-8,10-dihydro-7H-tetracene-5,12-dione
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-ethyl-1,4,6,7,8,10-pentahydroxy-7-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (7R-(7-alpha,8-beta,10-beta))-
- 5,12-Naphthacenedione, 8-ethyl-7,8,9,10-tetrahydro-1,4,6,8,10-pentahydroxy-7-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (7R-(7alpha,8beta,10beta))-
- (1R,2R,4S)-2-Ethyl-2,4,7,10,12-pentahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxooxan-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylamino)-alpha-L-lyxo-hexopyranoside
- (7R)-8-Ethyl-7,8,9,10-tetrahydro-1,4,6,8alpha,10alpha-pentahydroxy-7beta-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2beta-yl]-alpha-L-lyxo-hexopyranosyl]-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione
- (7R,8R,10S)-7-{[(2S,4S,5S,6S)-4-(DIMETHYLAMINO)-5-{[(2S,4S,5S,6S)-4-HYDROXY-6-METHYL-5-{[(2R,6S)-6-METHYL-5-OXOOXAN-2-YL]OXY}OXAN-2-YL]OXY}-6-METHYLOXAN-2-YL]OXY}-8-ETHYL-1,4,6,8,10-PENTAHYDROXY-5,7,8,9,10,12-HEXAHYDROTETRACENE-5,12-DIONE
- 2-Ethyl-2,4,7,10,12-pentahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-(6-methyl-5-oxooxan-2-yl)hexopyranosyl]-3-(dimethylamino)hexopyranoside
- 5,12-Naphthacenedione, 8-ethyl-7,8,9,10-tetrahydro-1,4,6,8,10-pentahydroxy-7-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)))-alpha(7R-(7alpha,8beta,10beta))-